House approves bill to authorize FDA‑approved synthetic psilocybin for medical use upon federal approval; debate raises safety and timing concerns

The Colorado House of Representatives on 2025-01-22 passed House Bill 1063 on second reading to make lawful the medical use of a crystalline synthetic psilocybin compound if and when it is approved by the U.S. Food and Drug Administration and rescheduled by the Drug Enforcement Administration.

Representative Hartzuck, a co-sponsor, framed the bill as a narrow, preemptive measure that would allow access to a synthetic, FDA‑approved medication once federal regulators complete trials and rescheduling. "My purpose in this bill ... is so we don't have to wait and veterans and people that have not responded to other treatments have to wait for us to come back here and get the wheels…